New cancer chemotherapy agents: Inhibitors of DNA polymerase

Current Drug Therapy

Volumn 3, Issue 1, 2008, Pages 44-53

  Sakaguchi, Kengo ^a   Sugawara, Fumio ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Cancer chemotherapy; Computer simulated molecular design; DNA polymerase inhibitor; Radiosensitizers; Sulfoquinovosylacylglycerols (SQAG); T7 phage display method

Indexed keywords

ALPHA SULFOQUINOVOSYL MONOACYLGLYCEROL; ANTINEOPLASTIC AGENT; DNA DIRECTED DNA POLYMERASE INHIBITOR; ENZYME INHIBITOR; RADIOSENSITIZING AGENT; SULFOQUINOVOSYL MONOACYLGLYCEROL DERIVATIVE; SULFOQUINOVOSYLACYLGLYCEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL SPECIFICITY; COMPUTER AIDED DESIGN; COMPUTER SIMULATION; DRUG DESIGN; DRUG ISOLATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NECROSIS; NEOPLASM; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 38949125404     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488508783331234     Document Type: Review

References (70)

1. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002; 109(Suppl): S45-55.
2. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol. 2000; 18: 495-527.
3. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994; 265: 103-6.
4. Hindges R, Hübscher U. DNA polymerase delta, an essential enzyme for DNA transactions. Biol Chem 1997; 378: 345-62.
5. Kim DR, Park SJ, Oettinger MA. V(D)J recombination: site-specific cleavage and repair. Mol Cells 2000; 10: 367-74.
6. Sugo N, Aratani Y, Nagashima Y, Kubota Y, Koyama H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO J 2000; 19: 1397-404.
7. Takata K, Ishikawa G, Hirose F, Sakaguchi K. Drosophila damage-specific DNA-binding protein 1 (D-DDB1) is controlled by the DRE/DREF system. Nucleic Acids Res 2002; 30: 3795-808.
8. Sono A, Sakaguchi K. Inhibition of protein synthesis antagonizes induction of sister-chromatid exchanges by exogenous agents. Mutat Res 1981; 80: 121-31.
9. Sono A, Sakaguchi K. Antagonization by cycloheximide of ethyl methanesulfonate-induced 6-thioguanine-resistant mutation and sister-chromatid exchanges. Mutat Res 1982; 106: 265-76.
10. Sono A, Sakaguchi K. Isolation of Chinese hamster cells hyposensitive to ethyl methanesulfonate and their characterization in induction and antagonization of sister-chromatid exchanges. Mutat Res 1984; 129: 181-94.
11. Sono A, Sakaguchi K. The influence of a protein synthesis inhibitor on sister-chromatid exchange in the plant Vicia faba. Mutat Res 1986; 173: 257-61.
12. Sono A, Sakaguchi K. Isolation and characterization of Chinese hamster cell line resistant to monofunctional alkylating agents. Somat Cell Mol Genet 1988; 14: 329-44.
13. Sakaguchi K, Sugawara F. Inhibitors of eukaryotic DNA polymerases. Curr Topics Med Chem 2003; 3: 1-33.
14. Sakaguchi K, Sugawara. F, Mizushina Y. [Inhibitors of eukaryotic DNA polymerases]. Seikagaku 2002; 74: 244-51.
15. Takahashi S, Kamisuki S, Mizushina Y, Sakaguchi Y, Sugawara, F, Nakata T. Total synthesis of dehydroaltenusin. Tetrahedron Lett 2003; 44: 1875-77.
16. Yamazaki T, Aoki S, Ohta K, Hyuma S, Sakaguchi K, Sugawara F. Synthesis of an immunosuppressant SQAG9 and determination of the binding peptide by T7 phage display. Bioorg Med Chem Lett 2004; 14: 4343-6.
17. Kamisuki S, Takahashi S, Mizushina Y, Sakaguchi K, Nakata T, Sugawara F. Precise structural elucidation of dehydroaltenusin, a specific inhibitor of mammalian DNA polymerase alpha. Bioorg Med Chem 2004; 12: 5355-9.
18. Kuramochi K, Mizushina Y, Nagata S, Sugawara F, Sakaguchi K, Kobayashi S. Structure-activity relationships of epolactaene analogs as DNA polymerases inhibitors. Bioorg Med Chem 2004; 12: 1983-9.
19. Oshige M, Takenouchi M Kato Y, et al. Taxol derivatives are selective inhibitors of DNA polymerase alpha. Bioorg Med Chem 2004; 12: 2597-601.
20. Mizushina Y, Kasai N, Miura K, et al. Structural relationship of lithocholic acid derivatives binding to the N-terminal 8-kDa domain of DNA polymerase beta. Biochemistry 2004; 43: 10669-77.
21. Kuramochi K, Haruyama T, Takeuchi R, et al. Affinity capture of a mammalian DNA polymerase beta by inhibitors immobilized to resins used in solid-phase organic synthesis. Bioconjug Chem 2005; 16:97-104.
22. Aoki S, Ohta Y, Yamazaki T, Sugawara F, Sakaguchi K. Mammalian mitotic centromere-associated kinesin (MCAK): a new molecular target of sulfoquinovosylacylglycerols novel antitumor and immunosuppressive agents. FEBS J 2005; 272: 2132-40.
23. Kuriyama I, Asano N, Kato I, et al. Dipeptide alcohol-based inhibitors of eukaryotic DNA polymerase alpha. Bioorg Med Chem 2005; 13: 2187-96.
24. Kasai N, Mizushina Y, Murata H, et al. Sulfoquinovosylmonoacylglycerol inhibitory mode analysis of rat DNA polymerase beta. FEBS J 2005; 272: 4349-61.
25. Takakusagi Y, Ohta K, Kuramochi K, et al. Synthesis of a biotinylated camptothecin derivative and determination of the binding sequence by T7 phage display technology. Bioorg Mod Chem Lett 2005; 15:4846-9.
26. Matsumoto K, Sakai H, Ohta K, et al. Monolayer membranes and bilayer vesicles characterized by alpha- and beta-anomer of sulfoquinovosyldiacyglycerol (SQDG). Chem Phys Lipids 2005; 133: 203-14.
27. Matsumoto K, Sakai H, Takeuchi R, et al. Effective form of sulfoquinovosyldiacyglycerol (SQDG) vesicles for DNA polymerase inhibition. Colloids Surf B Biointerfaces 2005; 46: 175-81.
28. Uchiyama Y, Tagami J, Kamisuki S, et al. Selective inhibitors of terminal deoxyribonucleotidyltransferase (TdT): baicalin and genistin. Biochim. Biophys Acta 2005; 1725: 298-304.
29. Morohashi K, Arai T, Saito S, Watanabe M, Sakaguchi K, Sugawara F. A high-throughput phage display screening method using a combination of real-time PCR and affinity chromatography. Comb Chem High Throughput Screen 2006; 9: 55-61.
30. Morohashi K, Yoshino A, Yoshimori A, et al. Identification of a drug target motif: an anti-tumor drug NK109 interacts with a PNxxxxP. Biochem Pharmacol 2005; 70: 37-46.
31. Murakami S, Kamisuki S, Takata K, et al. Site-directed mutational analysis of structural interactions of low molecule compounds binding to the N-terminal 8 kDa domain of DNA polymerase beta. Biochem Biophys Res Commun 2006; 350: 7-16.
32. Aoki S, Ohta K, Matsumoto K, et al. An emulsion of sulfoquinovosylacylglycerol with long-chain alkanes increases its permeability to tumor cells. J Membr Biol 2006; 213: 11-8.
33. Sakimoto I, Ohta K, Yamazaki T, et al. Alpha-sulfoquinovosylmonoacylglycerol is a novel potent radiosensitizer targeting tumor angiogenesis. Cancer Res 2006; 66: 2287-95.
34. Doncaster JR, Etchells LL, Kershaw NM, et al. Synthetic analogues of the manzamenones and plakoridines which inhibit DNA polymerase. Bioorg Med Chem Lett 2006; 16: 2877-81.
35. Mizushina Y, Nakanishi R, Kuriyama I, et al. Beta-sitosterol-3-O- beta-D-glucopyranoside: a eukaryotic DNA polymerase lambda inhibitor. J Steroid Biochem Mol Biol 2006; 99: 100-7.
36. Miura M, Sakimoto I, Ohta K, Sugawara F, Sakaguchi K. Sulfoglycolipids as candidate antiangiogenic radiosensitizers. Anticancer Drugs 2007; 18: 1-5.
37. Sakaguchi K, Koshiyama A, Iwabata K. Meiosis and small ubiquitin-related modifier (SUMO)-conjugating enzyme, Ubc9. FEBS J 2007; 274: 3519-31.
38. Kimura S, Sakaguchi K. DNA repair in plants. Chem Rev 2006; 106: 753-66.
39. Takeuchi R, Ruike T, Nakamura R, et al. Drosophila DNA polymerase zeta interacts with recombination repair protein 1, the Drosophila homologue of human abasic endonuclease 1. J Biol Chem 2006; 281: 11577-85.
40. Ruike T, Takeuchi R, Takata K, et al. Characterization of a second proliferating cell nuclear antigen (PCNA2) from Drosophila melanogaster. FEBS J 2006; 273: 5062-73.
41. Sahara H, Ishikawa M, Takahashi N, et al. In vivo anti-tumour effect of 3′-sulphonoquinovosyl 1′-monoacylglyceride isolated from sea urchin (Strongylocentrotus intermedius) intestine. Br J Cancer 1997; 75: 324-32.
42. Sahara H, Hanashima S, Yamazaki T, et al. Anti-tumor effect of chemically synthesized sulfolipids based on sea urchin's natural sulfonoquinovosylmonoacylglycerols. Jpn J Cancer Res 2002; 93: 85-92.
43. Matsumoto Y, Sahara H, Fujita S, et al. Inhibitory effect of mixed lymphocyte reaction by synthetic sulfolipids which are stereoisomers of sulfonoquinovosyldiacylglycerol derived from sea urchin. Bull. Marine Biomed lust Sapporo MED Univ School Med 1999; 4: 19-23.
44. Sugawara F, Hanashima S, Mizushina Y, et al. Approach of Chemical Biology: A case study on sulfolipids. From findings of natural products, structural determinations, chemical syntheses and pharmaceutical potentials to future therapeutic usage as a goal. Bull. Marine Biomed Inst Sapporo MED Univ School Med 1999; 4: 7-18.
45. Ohta K, Mizushina Y, Hirata N, et al. Sulfoquinovosyldiacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerases and HIV-reverse transcriptase type 1 from a marine red alga, Gigartina tenella. Chem Pharm Bull (Tokyo) 1998; 46: 684-6.
46. Ohta K, Mizushina Y, Hirata N, et al. Action of a new mammalian DNA polymerase inhibitor, sulfoquinovosyldiacylglycerol. Biol Pharm Bull 1999; 22: 111-6.
47. Ohta K, Hanashima S, Mizushina Y, et al. Studies on a novel DNA polymerase inhibitor group, synthetic sulfoguinovosylacylglycerols: inhibitory action on cell proliferation. Mutat Res 2000; 467: 139-52.
48. Ohta K, Mizushina, Y, Yamazaki T, Hanashima S, Sugawara F, Sakaguchi K. Specific interaction between an oligosaccharide on the tumor cell surface and the novel antitumor agents, sulfoquinovosylacylglycerols. Biochem Biophys Res Common 2001; 288: 893-900.
49. Hubscher U, Maga G, Spadari S. Eukaryotic DNA polymerases. Annu Rev Biochem 2002; 71: 133-63.
50. Kimura S, Uchiyama Y, Kasai N, et al. A novel DNA polymerase homologous to Escherichia coli DNA polymerase I from a higher plant, rice (Oryza sativa L.). Nucleic Acids Res 2002; 30: 1585-92.
51. Mori Y, Kimura S, Saotome A, et al. Plastid DNA polymerases from higher plants, Arabidopsis thaliana. Biochem Biophys Res Common 2005; 334: 43-50.
52. Takata K, Shimizu T, Iwai S, Wood RD. Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol. J Biol Chem 2006; 281: 23445-55.
53. Takeuchi R, Kimura S, Saotome A, Sakaguchi K. Biochemical properties of a plastidial DNA polymerase of rice. Plant Mol Biol 2007; 64: 601-11.
54. Uchiyama Y, Kimura S, Yamamoto T, Ishibashi T, Sakaguchi K. Plant DNA polymerase lambda, a DNA repair enzyme that functions in plant meristematic and meiotic tissues. Eur J Biochem 2004; 271: 2799-807.
55. Matsukage A, Nishikawa K, Ooi T, Seto Y, Yamaguchi M. Homology between mammalian DNA polymerase beta and terminal deoxynucleotidyltransferase. J Biol Chem 1987; 262: 8960-2.
56. Gustafson KR, Cardellina F, Rw W, et al. AIDS-antiviral sulfolipids from cyanobacter (blue-green algae). J Natl Cancer Inst 1989; 81: 1254-8.
57. Hanashima S, Mizushina Y, Ohta K, Yamazaki T, Sugawara F, Sakaguchi K. Structure-activity relationship of a novel group of mammalian DNA polymerase inhibitors, synthetic sulfoquinovosylacylglycerols. Jpn J Cancer Res 2000; 91: 1073-83.
58. Hanashima S, Mizushina Y, Yamazaki T, et al. Structural determination of sulfoquinovosyldiacylglycerol by chiral syntheses. Tetrahedron Lett 2000; 41: 4403-07.
59. Hanashima S, Mizushina Y, Yamazaki T, et al. Synthesis of sulfoquinovosylacylglycerols, inhibitors of eukaryotic DNA polymerase alpha and beta. Bioorg Med Chem 2001; 9: 367-76.
60. Mizushina Y, Ohkubo T, Date T, et al. Mode analysis of a fatty acid molecule binding to the N-terminal 8-kDa domain of DNA polymerase beta. A 1:1 complex and binding surface. J Biol Chem 1999; 274: 25599-607.
61. Mizushina Y, Sugawara F, Iida A, Sakaguchi K. Structural homology bevveen DNA binding sites of DNA polymerase beta and DNA topoisomerase II. J Mol Biol 2000; 304: 385-95.
62. Kojima N, Hakomori S. Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid inWraction. J Biol Chem 1991; 266: 17552-8.
63. Itzkowitz SH, Yuan M, Fukushi Y, et al. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues. Cancer Res 1988; 48: 3834-42.
64. Takada A, Ohmori K, Yoneda T, et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993; 53: 354-61.
65. Novagen. T7Select System Manual. Novagen 2000; TB178.
66. Hunter AW, Caplow M, Coy DL, et al. The kinesin-related protein MCAK is a microtubule depolymerase that forms an ATP-hydrolyzing complex at microtubule ends. Mol Cell 2003; 11: 445-57.
67. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70-4.
68. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998; 273: 18514-21.
69. Peters KG, Coogan A, Berry D, et al. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer 1998; 77: 51-6.
70. Stratmann A, Risau W, Plate KH. Cell type-specific expression of angiopoetin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998; 153: 1459-66.